All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @vivespamedico on TikTok · 27s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @vivespamedico's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I would recommend that for a recubinicity of P-mera sausage,
  2. 0:02these are the P-mera sausage and delicious tomatoes,
  3. 0:05the cheese and the delicious
  4. 0:25at the MBM Medical Spa.

GHK-Cu skin injections: what the collagen science actually shows

vivespamedico

TikTok creator

785.0K viewsWatch on TikTok

Quick answer

The video promotes injectable GHK-Cu (copper peptide) under the brand name NINE HILO as a skin booster for collagen and elastin stimulation. GHK-Cu has documented activity in collagen-related gene expression pathways in vitro, but controlled human trial data on injectable formulations specifically is limited. Patients considering this treatment should seek consultation with a licensed physician and verify the compounding pharmacy's credentials, as injectable GHK-Cu is not an FDA-approved pharmaceutical product.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GHK-Cu skin injections: what the collagen science actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GHK-Cu (Copper Peptide) should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GHK-Cu skin injections: what the collagen science actually shows" from vivespamedico. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video promotes injectable GHK-Cu (copper peptide) under the brand name NINE HILO as a skin booster for collagen and elastin stimulation.

The reason this review is not generic is the source wording and the canonical claim label "peptides quieres mejorar la calidad de tu piel sin perder naturalidad." In this clip, the useful excerpt is: "I would recommend that for a recubinicity of P-mera sausage, these are the P-mera sausage and delicious tomatoes, the cheese and the delicious at the MBM Medical Spa." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 1997 human study (Finkley et al.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video promotes injectable GHK-Cu (copper peptide) under the brand name NINE HILO as a skin booster for collagen and elastin stimulation.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video promotes injectable GHK-Cu (copper peptide) under the brand name NINE HILO as a skin booster for collagen and elastin stimulation. GHK-Cu has documented activity in collagen-related gene expression pathways in vitro, but controlled human trial data on injectable formulations specifically is limited. Patients considering this treatment should seek consultation with a licensed physician and verify the compounding pharmacy's credentials, as injectable GHK-Cu is not an FDA-approved pharmaceutical product.
  • GHK-Cu has over 30 years of research behind it, but the majority of skin-specific studies are in vitro or involve topical application, not injectable delivery.
  • A 1997 human study (Finkley et al., Journal of Geriatric Dermatology) showed topical GHK-Cu improved skin laxity, but topical and injectable pharmacokinetics are not equivalent.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • GHK-Cu has over 30 years of research behind it, but the majority of skin-specific studies are in vitro or involve topical application, not injectable delivery.
  • A 1997 human study (Finkley et al., Journal of Geriatric Dermatology) showed topical GHK-Cu improved skin laxity, but topical and injectable pharmacokinetics are not equivalent.
  • Injectable GHK-Cu is a compounded peptide, not an FDA-approved drug. Sterility standards and concentration accuracy depend entirely on the compounding pharmacy used.
  • Collagen gene activation in a cell study does not automatically translate to visible skin improvement in a clinical setting. The translational gap matters.
  • Pickart and Margolina (2018, Cosmetics) documented GHK-Cu's role in activating over 4,000 human genes related to tissue repair, which supports biological plausibility, but gene activation is not the same as a proven clinical outcome.
  • Anyone considering injectable peptide treatments should verify provider credentials, ask about the specific compounding pharmacy, and consult a board-certified dermatologist before proceeding.
  • The regulatory status of compounded injectable peptides varies by country. In the United States, compounded GHK-Cu is not FDA-approved and exists under specific compounding pharmacy regulations.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @vivespamedico actually say?

Honestly, the transcript we have is garbled to the point of being unusable as a direct source. The caption does most of the heavy lifting here, with the creator promoting a product called NINE HILO containing the copper peptide GHK-Cu (listed as CHK-Cu in the caption, likely a transcription error). The marketing claims include stimulating collagen and elastin, improving firmness, hydration, and skin texture, and achieving skin rejuvenation. These are specific biological claims about an injectable peptide, and they deserve real scrutiny rather than a pass because they sound reasonable.

The caption describes GHK-Cu as a "skin booster" administered via injection at a medical spa. That framing matters because injectables carry different risk profiles than topical products, and the regulatory status of compounded GHK-Cu injectables varies significantly by country.

Does the science back this up?

Partially, yes, but the gap between what cell studies show and what injecting this into a human face does is larger than this video implies. GHK-Cu has a reasonably interesting research profile, but most of it comes from in vitro work and animal models, not robust randomized controlled trials in humans.

Pickart and Margolina (2018, Cosmetics) summarized decades of GHK-Cu research, noting its role in activating genes associated with collagen synthesis and wound repair. That is real. However, moving from "activates collagen genes in a lab dish" to "rejuvenates your skin after injection at a med spa" involves several leaps the science has not fully bridged. A small human study by Finkley et al. (1997, Journal of Geriatric Dermatology) found topical GHK-Cu improved skin laxity markers, but topical delivery and injectable delivery are entirely different pharmacokinetic scenarios. Human RCT data on injectable GHK-Cu specifically is thin. The collagen and elastin stimulation angle has support in principle; the clinical magnitude of that effect in humans via injection remains poorly quantified.

What did they get wrong (or right)?

What they got right: GHK-Cu does have real biological activity related to collagen and wound healing pathways. This is not snake oil. Pointing people toward a peptide with actual mechanistic data is a step above most TikTok skin content.

What they got wrong, or at least glossed over: framing this as a clear rejuvenation treatment without flagging that injectable GHK-Cu is not FDA-approved as a drug, and that compounded versions exist in a regulatory gray zone, is an omission that matters for a 785,000-view video. The caption presents collagen and elastin stimulation as an established outcome rather than a plausible but not fully proven one. There is also no discussion of injection site risks, the importance of provider qualifications, or why someone might not be a good candidate. Calling it a treatment that achieves rejuvenation while "maintaining naturalness" is marketing language layered over incomplete clinical evidence.

What should you actually know?

GHK-Cu is a tripeptide naturally present in human plasma, saliva, and urine. Its concentration declines with age, which is part of why researchers got interested in it. The peptide binds copper ions and has shown activity in studies involving collagen production, antioxidant response, and tissue repair signaling (Pickart, 2008, Journal of Biomaterials Science).

For someone considering an injectable skin treatment based on content like this, a few things are worth knowing:

  • Injectable GHK-Cu is typically compounded, meaning it is not a standardized FDA-approved product. Quality, sterility, and concentration can vary between compounding pharmacies.
  • Most published human evidence for GHK-Cu skin effects involves topical formulations, not injectables. The two are not interchangeable in terms of what we know about efficacy and safety.
  • A consultation with a board-certified dermatologist or plastic surgeon, not just a med spa, is appropriate before any injectable treatment.
  • "Natural-looking" results and "rejuvenation" are subjective terms with no regulatory definition. Ask for before-and-after data from the specific provider, not from a social media caption.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

vivespamedico · TikTok creator

785.0K views on this video

“✨ ¿Quieres mejorar la calidad de tu piel sin perder naturalidad? Esto te va a encantar 🤍 El Dr. Darío presenta NINE HILO, un tratamiento inyectable con péptido de cobre CHK-Cu 🧬✨ Ayuda a estimular colágeno y elastina, mejora la firmeza, hidratación y textura de la piel, logrando un rejuvenecimiento visible pero natural 💫 💥 Disponible ahora con promoción exclusiva 📍 Solo en Vive Med Spa 📲 Agenda tu cita y eleva la calidad de tu piel ✨ ________ ✨ Want to improve your skin quality witho

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu has over 30 years of research behind it,?

GHK-Cu has over 30 years of research behind it, but the majority of skin-specific studies are in vitro or involve topical application, not injectable delivery.

What does the video say about a 1997 human study (finkley et al., journal of geriatric?

A 1997 human study (Finkley et al., Journal of Geriatric Dermatology) showed topical GHK-Cu improved skin laxity, but topical and injectable pharmacokinetics are not equivalent.

What does the video say about injectable ghk-cu?

Injectable GHK-Cu is a compounded peptide, not an FDA-approved drug. Sterility standards and concentration accuracy depend entirely on the compounding pharmacy used.

What does the video say about collagen gene activation in a cell study does not automatically?

Collagen gene activation in a cell study does not automatically translate to visible skin improvement in a clinical setting. The translational gap matters.

What does the video say about pickart?

Pickart and Margolina (2018, Cosmetics) documented GHK-Cu's role in activating over 4,000 human genes related to tissue repair, which supports biological plausibility, but gene activation is not the same as a proven clinical outcome.

What does the video say about anyone considering injectable peptide treatments should verify provider credentials, ask?

Anyone considering injectable peptide treatments should verify provider credentials, ask about the specific compounding pharmacy, and consult a board-certified dermatologist before proceeding.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by vivespamedico, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.